GO:0004575 sucrose alpha-glucosidase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0004575 sucrose alpha-glucosidase activity describes the catalysis of sucrose hydrolysis into alpha-D-glucose and beta-D-fructose, a central reaction in carbohydrate digestion and glucose homeostasis.
• The term is synonymous with sucrase, invertase, and sucrase-isomaltase activity, reflecting its historical and biochemical contexts [1, 3].
• Inhibitors of alpha-glucosidase activity, such as acarbose and various plant-derived flavonoids, are used to manage postprandial hyperglycemia in diabetes research [1, 3, 4].
• Enzymatic activity is commonly measured using chromogenic or fluorogenic substrates in vitro, and its inhibition is a standard screen for antidiabetic compounds [5, 7, 8].
• The activity is relevant to microbial pathogenesis, as seen in Candida albicans mutants lacking sucrose-inhibitable alpha-glucosidase.
• CRISPR-based models (knockout, point mutation, knock-in, overexpression) enable causal interrogation of genes encoding sucrose alpha-glucosidase activity in metabolic and infectious disease contexts.
Description
Sucrose alpha-glucosidase activity (GO:0004575) is a molecular function defined by the hydrolysis of sucrose into alpha-D-glucose and beta-D-fructose. This enzymatic activity is fundamental to carbohydrate metabolism and is a well-established target for modulating blood glucose levels in diabetes research [1, 3]. The term encompasses several synonyms, including sucrase, invertase, and sucrase-isomaltase activity, reflecting its occurrence across diverse organisms and tissues [1, 6]. Researchers study this activity to understand dietary sugar processing, to screen for alpha-glucosidase inhibitors, and to investigate host-microbe interactions [4, 5, 7]. The reaction is catalyzed by enzymes that are often membrane-bound in the small intestine, where they play a direct role in the final steps of carbohydrate digestion. Given its central role in glucose homeostasis, sucrose alpha-glucosidase activity remains a high-priority target for therapeutic intervention in metabolic disorders [1, 8].
sucrose alpha-glucosidase activity At A Glance
| GO ID | GO:0004575 |
|---|---|
| GO term | sucrose alpha-glucosidase activity |
| Ontology | molecular_function |
| Synonym | sucrase activity; invertase activity; sucrase-isomaltase activity; intestinal sucrase activity; sucrose alpha-D-glucohydrolase activity |
| Definition | Catalysis of the reaction: sucrose + H2O = alpha-D-glucose + beta-D-fructose. |
| Major function | Hydrolysis of sucrose into glucose and fructose, contributing to carbohydrate digestion and glucose homeostasis. |
| Reaction direction | Irreversible hydrolysis under physiological conditions. |
| Cellular location | Typically associated with the brush border membrane of enterocytes and extracellular or vacuolar compartments in microorganisms. |
| Inhibitors | Acarbose, flavonoids, methyl caffeate, and various plant polysaccharides. |
What Is GO:0004575?
According to the Gene Ontology, sucrose alpha-glucosidase activity (GO:0004575) is the catalysis of the reaction: sucrose + H2O = alpha-D-glucose + beta-D-fructose. In other words, it is the enzymatic hydrolysis of the disaccharide sucrose into its monosaccharide components, alpha-D-glucose and beta-D-fructose. This activity is synonymous with sucrase, invertase, and sucrase-isomaltase activity, among other names.
Why Is sucrose alpha-glucosidase activity Important in Cell Biology?
Sucrose alpha-glucosidase activity is a critical control point in carbohydrate metabolism because it directly determines the rate at which dietary sucrose is converted into absorbable monosaccharides, thereby influencing postprandial blood glucose excursions [1, 3]. Inhibiting this activity is a proven strategy for managing hyperglycemia in type 2 diabetes, as demonstrated by the clinical use of acarbose and the ongoing search for natural inhibitors from dietary sources [1, 4, 5, 7, 8]. Beyond metabolic disease, the activity is also relevant to microbial pathogenesis, where it can contribute to host colonization and virulence. Consequently, understanding its mechanism, regulation, and genetic determinants is essential for developing targeted therapies and for interpreting metabolic phenotypes in model organisms.
• Central to the final step of sucrose digestion in the small intestine, directly affecting blood glucose levels.
• A validated drug target for type 2 diabetes; alpha-glucosidase inhibitors like acarbose reduce postprandial hyperglycemia [1, 3].
• Serves as a screening target for natural product-derived antidiabetic compounds, including flavonoids and polysaccharides [4, 5, 7, 8].
• Relevant to microbial pathogenesis, as some pathogens express sucrose-inhibitable alpha-glucosidases.
• Provides a biochemical marker for intestinal disaccharidase deficiencies and malabsorption syndromes.
• Enables research on carbohydrate metabolism in model organisms such as KK-Ay and ddY mice.
• Offers a paradigm for studying enzyme inhibition kinetics and structure-activity relationships.
• Supports the development of functional foods and nutraceuticals aimed at glycemic control [7, 8].
• Facilitates comparative studies of glycoside hydrolase families across species.
• Underpins CRISPR-based functional genomics to identify genes modulating sucrose hydrolysis.
Molecular Mechanism of sucrose alpha-glucosidase activity
Substrate recognition and binding
In simple terms: The enzyme grabs sucrose and holds it in place.
Sucrose alpha-glucosidase enzymes bind the disaccharide sucrose in their active site through a combination of hydrogen bonds and hydrophobic interactions. The enzyme specifically recognizes the alpha-1,2-glycosidic linkage between glucose and fructose. This binding is often competitively inhibited by structural analogs such as acarbose or flavonoids, which occupy the active site and prevent sucrose access [1, 3, 4].
Catalytic hydrolysis
In simple terms: The enzyme uses water to split sucrose into two sugars.
The catalytic mechanism involves acid-base catalysis, where a water molecule attacks the glycosidic oxygen, leading to cleavage of the bond and release of alpha-D-glucose and beta-D-fructose. This hydrolysis is essentially irreversible under physiological conditions. The reaction is commonly measured by detecting the release of glucose using coupled enzymatic assays or chromogenic substrates [5, 7, 8].
Cofactors and structural requirements
In simple terms: The enzyme needs a specific shape and sometimes helper molecules to work.
Most sucrose alpha-glucosidases do not require metal cofactors, but their activity depends on proper folding and, in some cases, glycosylation. For example, the sucrase-isomaltase complex is a membrane-bound glycoprotein whose activity can be affected by mutations or processing defects. Inhibitor studies have shown that the active site contains key acidic residues essential for catalysis, as evidenced by pH-dependent activity profiles [4, 5].
Regulation and inhibition
In simple terms: The enzyme's activity can be turned up or down by other molecules.
Sucrose alpha-glucosidase activity is regulated at multiple levels, including gene expression, post-translational modifications, and interaction with inhibitors. Dietary flavonoids and plant extracts have been shown to inhibit the activity in vitro and in vivo, leading to reduced blood glucose elevation in animal models [1, 4, 7, 8]. In pathogenic fungi, the expression of sucrose-inhibitable alpha-glucosidase can influence virulence and host interaction. These regulatory mechanisms are exploited in drug discovery and functional studies.
Key Genes Involved in GO:0004575 sucrose alpha-glucosidase activity
The following genes encode proteins that exhibit sucrose alpha-glucosidase activity or are directly involved in its regulation and function.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SI | Encodes sucrase-isomaltase, a brush-border enzyme with sucrose alpha-glucosidase activity | Mutations cause congenital sucrase-isomaltase deficiency; target for disaccharidase research |
| MGAM | Encodes maltase-glucoamylase, which also has sucrase activity | Studied for its role in starch and sucrose digestion; potential target for diabetes |
| GAA | Encodes acid alpha-glucosidase, which can hydrolyze sucrose at acidic pH | Deficiency causes Pompe disease; used as a model for lysosomal glycogen storage |
| SI (mouse) | Murine sucrase-isomaltase | Used in KK-Ay and ddY mouse models to study disaccharidase activity and acarbose effects |
| C. albicans INT1 | Sucrose-inhibitable alpha-glucosidase in Candida albicans | Linked to adhesion and virulence; mutant strains lack activity |
| SUC2 (yeast) | Invertase that hydrolyzes sucrose | Model for secretory pathway and glycoprotein processing; not directly cited but homologous |
| TREH | Trehalase, not sucrose alpha-glucosidase, but related disaccharidase | Used as a comparative enzyme in inhibition studies |
| AMY1 | Alpha-amylase, acts on starch not sucrose | Often co-assayed with alpha-glucosidase in inhibitor screens |
| AMY2 | Pancreatic alpha-amylase | Similar co-assay context |
| LCT | Lactase, another brush-border disaccharidase | Relevant to disaccharidase insufficiency research |
| SLC5A1 | Sodium-glucose cotransporter, downstream of glucose release | Not directly sucrose alpha-glucosidase but linked to glucose uptake |
| SLC2A2 | GLUT2 transporter | Facilitates glucose exit from enterocytes after hydrolysis |
| PRKAA1 | AMPK catalytic subunit, energy sensor | May regulate carbohydrate metabolism indirectly |
| PRKAA2 | AMPK catalytic subunit | Same as above |
| INS | Insulin | Regulates blood glucose; used as endpoint in inhibitor studies |
| GCG | Glucagon | Counter-regulatory hormone; relevant to glucose homeostasis |
| DPP4 | Dipeptidyl peptidase-4 | Incretin degradation; often studied alongside alpha-glucosidase inhibitors |
| SLC5A2 | SGLT2, renal glucose reabsorption | Target of antidiabetic drugs; complementary to alpha-glucosidase inhibition |
How Is sucrose alpha-glucosidase activity Regulated?
Sucrose alpha-glucosidase activity is regulated primarily at the level of gene expression and through direct inhibition by small molecules. Dietary flavonoids and plant-derived compounds such as methyl caffeate and saponarin have been shown to inhibit the activity in vitro and reduce postprandial blood glucose in animal models [1, 4, 5]. In the small intestine, the activity of sucrase-isomaltase can be modulated by dietary carbohydrate content and hormonal signals, although specific transcriptional regulators are not fully defined in the cited literature. In pathogenic fungi, the expression of sucrose-inhibitable alpha-glucosidase is linked to morphological transitions and virulence. Additionally, the activity can be affected by mutations in the SI gene, leading to congenital sucrase-isomaltase deficiency.
sucrose alpha-glucosidase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SI | Congenital sucrase-isomaltase deficiency | Knockout of SI in intestinal cell lines (e.g., Caco-2) or mouse models |
| MGAM | Starch and sucrose intolerance | Knockout mice or CRISPR-edited organoids |
| GAA | Pompe disease (glycogen storage disease type II) | Point mutation knock-in in GAA to mimic infantile-onset |
| C. albicans INT1 | Fungal virulence and adhesion | CRISPR knockout in Candida albicans to assess infectivity |
| TREH | Trehalase deficiency (rare) | Overexpression or knockout in cell models to study disaccharidase specificity |
Diabetes and metabolic disorders
Inhibition of sucrose alpha-glucosidase activity is a therapeutic strategy for type 2 diabetes mellitus. Acarbose, a clinically used inhibitor, reduces postprandial blood glucose by delaying sucrose digestion [1, 3]. Natural inhibitors from Tinospora cordifolia, Solanum torvum, and Pelvetia babingtonii have shown hypoglycemic effects in animal models [4, 5, 7]. Polysaccharides from Diaphragma juglandis fructus also inhibit alpha-glucosidase and mitigate streptozotocin-induced hyperglycemia. These studies underscore the disease relevance of this enzymatic activity.
Congenital sucrase-isomaltase deficiency
Mutations in the SI gene, which encodes the enzyme complex possessing sucrose alpha-glucosidase activity, cause congenital sucrase-isomaltase deficiency. This condition presents with osmotic diarrhea and malabsorption when sucrose is consumed. The study of this disease has illuminated the importance of proper enzyme trafficking and function in the brush border membrane.
Microbial pathogenesis
Candida albicans strains that do not express sucrose-inhibitable alpha-glucosidase exhibit altered phenotypes, suggesting a role in host colonization or virulence. This highlights the broader relevance of the activity beyond human metabolism.
From sucrose alpha-glucosidase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of SI abolish sucrose alpha-glucosidase activity? | SI knockout in Caco-2 or HEK293 cells |
| Does a specific point mutation in the active site impair catalysis? | Point mutation knock-in of catalytic residues in SI or MGAM |
| Can a disease-associated mutation be corrected? | Knock-in of wild-type SI in patient-derived iPSCs |
| Does overexpression of GAA increase sucrose hydrolysis? | Overexpression of GAA in mammalian cells |
| Which genes modulate alpha-glucosidase inhibitor sensitivity? | CRISPR library screening in a suitable cell line |
| How does Candida albicans alpha-glucosidase affect host interaction? | Knockout of INT1 in C. albicans and infection assays |
How to Study the sucrose alpha-glucosidase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Chromogenic substrate assay | Enzyme activity via release of p-nitrophenol | Inhibitor screening and kinetic studies [1, 5] |
| Glucose oxidase/peroxidase coupled assay | Glucose released from sucrose | Quantification of activity in biological samples [7, 8] |
| Oral sucrose tolerance test | Blood glucose elevation after sucrose load | In vivo evaluation of inhibitors [3, 7] |
| qRT-PCR | mRNA expression of SI, MGAM, GAA | Gene regulation studies |
| Western blot | Protein expression and processing | Validation of knockout or overexpression |
| CRISPR knockout | Loss of gene function | Causal testing of candidate genes |
| CRISPR point mutation | Specific amino acid changes | Structure-function analysis of active site |
| CRISPR library screening | Phenotypic selection for activity modulators | Discovery of novel regulators |
Enzymatic activity assays
Sucrose alpha-glucosidase activity is typically measured using chromogenic substrates such as p-nitrophenyl-alpha-D-glucopyranoside or by coupling glucose release to a glucose oxidase/peroxidase readout. These assays are used to screen inhibitors and to quantify activity in tissue homogenates or purified enzyme preparations [1, 4, 5, 7, 8].
In vivo glucose tolerance tests
Animal models such as KK-Ay and ddY mice are used to assess the effect of alpha-glucosidase inhibitors on blood glucose levels after sucrose loading. These studies provide physiological relevance to in vitro findings [3, 7, 8].
Gene expression analysis
Quantitative RT-PCR and RNA-seq can measure the expression of genes encoding sucrose alpha-glucosidases (e.g., SI, MGAM) under different conditions or in disease models. This helps link transcriptional regulation to enzymatic activity.
CRISPR-based functional genomics
CRISPR knockout, point mutation, and overexpression models enable causal testing of specific genes in sucrose hydrolysis. Library screening can identify novel regulators of alpha-glucosidase activity or inhibitor resistance.
How CRISPR Can Be Used to Study GO:0004575 sucrose alpha-glucosidase activity
Knockout
CRISPR knockout of SI or MGAM can abolish sucrose alpha-glucosidase activity in cell models, providing a clean background to study the contribution of each enzyme. This is particularly useful for dissecting the roles of sucrase-isomaltase versus maltase-glucoamylase in sucrose digestion.
Point Mutation
Introducing point mutations in catalytic residues of SI or MGAM allows precise testing of their role in sucrose hydrolysis. Such models can mimic naturally occurring mutations that cause enzyme deficiency or alter substrate specificity.
Knock-in
Knock-in of disease-associated mutations or reporter tags (e.g., GFP) into the endogenous SI locus enables real-time tracking of enzyme localization and function in physiologically relevant cells.
Overexpression
Overexpression of GAA or other alpha-glucosidases in mammalian cells can increase sucrose hydrolysis capacity, facilitating biochemical purification and inhibitor testing. This approach is also used to study enzyme trafficking and processing.
How EDITGENE Supports sucrose alpha-glucosidase activity Research
Researchers studying sucrose alpha-glucosidase activity-related genes often need to determine whether a candidate gene is causally involved in sucrose hydrolysis, glucose homeostasis, or inhibitor response. EDITGENE provides a comprehensive suite of CRISPR-based services to generate precisely engineered cell models, enabling rigorous functional validation and accelerating therapeutic discovery.
Contact EDITGENE today to design your custom CRISPR model for sucrose alpha-glucosidase activity research.
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| SI Knockout HEK293 Cell Line | EDJ-KQ2510 | Human | 6476 | Details Get a Quote |
| SI Knockout HeLa Cell Line | EDJ-KQ54466 | Human | 6476 | Details Get a Quote |
| SI Knockout A-549 Cell Line | EDJ-KQ62954 | Human | 6476 | Details Get a Quote |
| SI Knockout HCT 116 Cell Line | EDJ-KQ71426 | Human | 6476 | Details Get a Quote |
Frequently Asked Questions About sucrose alpha-glucosidase activity
What is sucrose alpha-glucosidase activity?
Sucrose alpha-glucosidase activity (GO:0004575) is the enzymatic catalysis of sucrose hydrolysis into alpha-D-glucose and beta-D-fructose, as defined by the Gene Ontology.
What genes are involved in sucrose alpha-glucosidase activity?
Key genes include SI (sucrase-isomaltase), MGAM (maltase-glucoamylase), and GAA (acid alpha-glucosidase), among others [1, 2, 3].
How is sucrose alpha-glucosidase activity measured?
It is commonly measured using chromogenic substrates or coupled glucose assays that detect the release of glucose from sucrose [1, 5, 7].
What diseases are associated with sucrose alpha-glucosidase activity?
It is linked to type 2 diabetes, congenital sucrase-isomaltase deficiency, and certain microbial infections [1, 2, 6].
What are inhibitors of sucrose alpha-glucosidase activity?
Acarbose, flavonoids, methyl caffeate, and various plant polysaccharides are known inhibitors [1, 3, 4, 5, 7, 8].
How can CRISPR be used to study sucrose alpha-glucosidase activity?
CRISPR knockout, point mutation, knock-in, and overexpression models allow causal testing of genes encoding or regulating this activity.
Is sucrose alpha-glucosidase activity the same as sucrase activity?
Yes, sucrase activity is a synonym for sucrose alpha-glucosidase activity, reflecting its role in hydrolyzing sucrose.
What is the reaction catalyzed by sucrose alpha-glucosidase?
The reaction is: sucrose + H2O = alpha-D-glucose + beta-D-fructose.
Which organisms have sucrose alpha-glucosidase activity?
It is found in humans, other mammals, plants, and microorganisms such as Candida albicans.
Why is sucrose alpha-glucosidase activity important for diabetes research?
Inhibiting this activity reduces postprandial blood glucose, making it a validated target for antidiabetic drug development [1, 3, 7, 8].
Conclusion
Sucrose alpha-glucosidase activity (GO:0004575) is a fundamental molecular function with broad implications for human health, particularly in glucose homeostasis and diabetes management. The enzyme's ability to hydrolyze sucrose into absorbable monosaccharides makes it a prime target for therapeutic intervention, as evidenced by the clinical use of acarbose and the ongoing discovery of natural inhibitors [1, 3, 4, 5, 7, 8]. Beyond metabolic disease, the activity plays a role in microbial pathogenesis and congenital disorders [2, 6]. Advances in CRISPR-based genome editing now enable precise interrogation of the genes responsible for this activity, paving the way for novel insights and targeted therapies. EDITGENE's services support these efforts by providing custom-engineered cell models for functional studies.
References
- 1. Pereira DF et al.. 2011. Effects of flavonoids on α-glucosidase activity: potential targets for glucose homeostasis.. Nutrition 27(11-12):1161-7 PMID: 21684120
- 2. Forget P et al.. 1985. Lactase insufficiency revisited.. J Pediatr Gastroenterol Nutr 4(6):868-72 PMID: 3934358
- 3. Miura T et al.. 1998. Effect of acarbose (alpha-glucosidase inhibitor) on disaccharase activity in small intestine in KK-Ay and ddY mice.. J Nutr Sci Vitaminol (Tokyo) 44(3):371-9 PMID: 9742458
- 4. Sengupta S et al.. 2009. Hypoglycemic activity of the antioxidant saponarin, characterized as alpha-glucosidase inhibitor present in Tinospora cordifolia.. J Enzyme Inhib Med Chem 24(3):684-90 PMID: 18951283
- 5. Takahashi K et al.. 2010. Methyl caffeate as an alpha-glucosidase inhibitor from Solanum torvum fruits and the activity of related compounds.. Biosci Biotechnol Biochem 74(4):741-5 PMID: 20378981
- 6. Kwon-Chung KJ et al.. 1990. Evidence that Candida stellatoidea type II is a mutant of Candida albicans that does not express sucrose-inhibitable alpha-glucosidase.. Infect Immun 58(9):2804-8 PMID: 1974885
- 7. Ohta T et al.. 2002. Alpha-glucosidase inhibitory activity of a 70% methanol extract from ezoishige (Pelvetia babingtonii de Toni) and its effect on the elevation of blood glucose level in rats.. Biosci Biotechnol Biochem 66(7):1552-4 PMID: 12224640
- 8. Meng Q et al.. 2019. Inhibitory effects of polysaccharide from Diaphragma juglandis fructus on α-amylase and α-d-glucosidase activity, streptozotocin-induced hyperglycemia model, advanced glycation end-products formation, and H(2)O(2)-induced oxidative damage.. Int J Biol Macromol 124:1080-1089 PMID: 30521898
